Trials / Completed
CompletedNCT01200251
Study of Bimatoprost Gel on Eyelash Growth
The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bimatoprost eyelash gel | Bimatoprost 0.03% solution was compounded into a gel - patients used on eyelash margin once daily placing gel with a fingertip or Q-tip for 6 months |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2007-09-01
- Completion
- 2008-12-01
- First posted
- 2010-09-13
- Last updated
- 2014-07-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01200251. Inclusion in this directory is not an endorsement.